Actinium Pharmaceuticals, Inc. Balance Sheet
ATNM|6 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 6 fiscal years. All figures from audited SEC 10-K filings.
Actinium Pharmaceuticals, Inc. had $52M in total assets and $8M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -8.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2011 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $48.0M | $72.9M | $76.7M | $108.9M | $77.8M | $5.7M |
| Current Assets | $49.4M | $74.5M | $78.3M | $110.9M | $79.7M | $6.2M |
| PP&E (Net) | $295.0K | $364.0K | $550.0K | $604.0K | $340.0K | $1.2K |
| Total Assets | $51.8M | $76.9M | $81.4M | $114.2M | $80.4M | $6.2M |
| Current Liabilities | $8.0M | $8.1M | $8.5M | $10.6M | $6.8M | $5.2M |
| Shareholders' Equity | $7.8M | $36.4M | $66.5M | $73.5M | $73.5M | $992.0K |